Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2006 1
2007 1
2008 1
2009 3
2010 2
2011 9
2012 7
2013 6
2014 4
2015 9
2016 8
2017 7
2018 7
2019 6
2020 6
2021 18
2022 12
2023 15
2024 17
2025 16
2026 10

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

149 results

Results by year

Filters applied: . Clear all
Page 1
Diffusion MRI and α-Synuclein Seed Amplification Status in Parkinson's Disease.
Chiu SY, Wang WE, Chen R, DeSimone JC, Archer DB, Adler CH, Mehta SH, Dresler SR, Armstrong MJ, McFarland N, Okun M, Vaillancourt DE; Parkinson's Progression Markers Initiative. Chiu SY, et al. Ann Neurol. 2026 May 7. doi: 10.1002/ana.78252. Online ahead of print. Ann Neurol. 2026. PMID: 42095555
Developing a Virtual Research Environment in the Parkinson's Progression Markers Initiative: myPPMI.
Stanley CE Jr, Fabrizio K, McMahon BA, Matthews-McGee A, Fitzgerald C, Singh Z, Rigby NH, Talarico JM, Brown EG, Korell M, McGuire Kuhl M, Destro C, Pavese N, Garrido A, Mollenhauer B, Chowdhury S, Marek K, Tanner CM, Tropea TF; Parkinson's Progression Markers Initiative. Stanley CE Jr, et al. Ann Neurol. 2026 Apr 21. doi: 10.1002/ana.78230. Online ahead of print. Ann Neurol. 2026. PMID: 42015362
Partnering With Participant Advisors on the Parkinson's Progression Markers Initiative.
McGuire Kuhl M, Destro C, Dobkin RD, Tropea TF, Brodkin K, Flagg E, Lemon LP, Henry B, McMahon BA, Stanley CE Jr, Matthews-McGee A, Heathers LEA, Miller M, Myers H, Foroud T, Pico C, Kelliher C, Kopil CM, Dance A, Duggan B, Goldstein FS, Robinson BS, Robinson J, Acevedo M, Clark M, Hidaka C, Moran J, Lugo P, Sugihara S, Paulson RD, Alongi PT, Comerci L, Kwok K, Kramer H, Marek K; Parkinson's Progression Markers Initiative. McGuire Kuhl M, et al. Ann Neurol. 2026 Apr 21. doi: 10.1002/ana.78220. Online ahead of print. Ann Neurol. 2026. PMID: 42012017
Predictive Factors and Impact of Significant Weight Loss on Quality of Life in Parkinson's Disease: A 5-Year Follow-Up Study.
Vidal ÁS, Santos-García D, de Deus Fonticoba T, Jesús S, Cosgaya M, Caldentey JG, Caballol N, Legarda I, Vara JH, Cabo I, Manzanares LL, Aramburu IG, Rivera AA, Mayordomo VG, Nogueira V, García-Soto JD, Borrué C, Vila BS, Sauco MÁ, Mir P; COPPADIS Study Group. Vidal ÁS, et al. Mov Disord Clin Pract. 2026 Feb 23. doi: 10.1002/mdc3.70552. Online ahead of print. Mov Disord Clin Pract. 2026. PMID: 41730672
Toward Harmonizing Quantification of Dopamine Neuron Imaging Biomarkers in Parkinson's Disease: The Centamine Scale.
Fan Z, Searle G, Rizzo G, Albani J, Cella P, Comley R, Klein G, Passamonti L, Salinas C, Schwarz AJ, Iaccarino L, Tamagnan G, Eberling J, Marek K, Seibyl J, Gunn RN; Parkinson's Progression Markers Initiative. Fan Z, et al. Ann Neurol. 2026 Apr;99(4):949-963. doi: 10.1002/ana.78116. Epub 2026 Jan 20. Ann Neurol. 2026. PMID: 41556298 Free PMC article.
149 results